XOMA Corp (XOMA)
25.64
-0.45
(-1.72%)
USD |
NASDAQ |
Apr 24, 16:00
25.86
+0.22
(+0.86%)
After-Hours: 20:00
XOMA Cash from Financing (TTM): 120.59M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 120.59M |
September 30, 2023 | -5.223M |
June 30, 2023 | -5.115M |
March 31, 2023 | -5.084M |
December 31, 2022 | -4.451M |
September 30, 2022 | -4.568M |
June 30, 2022 | -4.844M |
March 31, 2022 | 14.10M |
December 31, 2021 | 12.84M |
September 30, 2021 | 37.44M |
June 30, 2021 | 37.65M |
March 31, 2021 | 18.89M |
December 31, 2020 | 19.79M |
September 30, 2020 | 17.72M |
June 30, 2020 | 25.66M |
March 31, 2020 | 29.60M |
December 31, 2019 | 30.49M |
September 30, 2019 | 29.46M |
June 30, 2019 | 30.34M |
March 31, 2019 | 27.42M |
December 31, 2018 | 29.94M |
September 30, 2018 | 10.80M |
June 30, 2018 | 7.754M |
March 31, 2018 | 7.703M |
December 31, 2017 | 13.26M |
Date | Value |
---|---|
September 30, 2017 | 10.49M |
June 30, 2017 | 4.232M |
March 31, 2017 | 4.228M |
December 31, 2016 | -6.942M |
September 30, 2016 | -5.016M |
June 30, 2016 | -3.054M |
March 31, 2016 | -3.072M |
December 31, 2015 | 13.80M |
September 30, 2015 | 50.60M |
June 30, 2015 | 49.72M |
March 31, 2015 | 48.84M |
December 31, 2014 | 35.56M |
September 30, 2014 | 53.76M |
June 30, 2014 | 83.58M |
March 31, 2014 | 83.62M |
December 31, 2013 | 83.39M |
September 30, 2013 | 66.18M |
June 30, 2013 | 41.05M |
March 31, 2013 | 41.08M |
December 31, 2012 | 79.78M |
September 30, 2012 | 53.36M |
June 30, 2012 | 51.92M |
March 31, 2012 | 58.51M |
December 31, 2011 | 43.98M |
September 30, 2011 | 62.67M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-5.223M
Minimum
Sep 2023
120.59M
Maximum
Dec 2023
20.80M
Average
18.89M
Median
Mar 2021
Cash from Financing (TTM) Benchmarks
Kinnate Biopharma Inc (DELISTED) | -7.808M |
Societal CDMO Inc (DELISTED) | 2.342M |
Corcept Therapeutics Inc | -148.72M |
Sarepta Therapeutics Inc | 125.00M |
AbbVie Inc | -17.22B |